Find an Anesthesiologist | Anesthesiologist Directory | Anesthesiology Resources Online
Medicine News » Anesthesiology News » For AMD, Off-Label Avastin Cheaper Than On-Label Lucentis - Medscape
 

For AMD, Off-Label Avastin Cheaper Than On-Label Lucentis - Medscape

Posted on April 27th, 2012, 3:56 pm


For AMD, Off-Label Avastin Cheaper Than On-Label Lucentis
Medscape
April 27, 2012 — Ophthalmologists often use bevacizumab (Avastin, Genentech) off-label to treat wet age-related macular degeneration (AMD) in part because of lower cost compared with on-label use of ranibizumab (Lucentis, Genentech).

and more »
...

Recommend this news article 0